Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
tanj
Oct 4, 2024, 15:19 |
Blog
Tanja Obradovic: FDA granted approval to selpercatinib for advanced or metastatic medullary thyroid cancer with a RET mutation
Tanja Obradovic shared a post on LinkedIn: "Outstanding news for patients with metastatic medulary thyroid…
Oct 3, 2024, 07:22 |
Blog
Tanja Obradovic: AbbVie submitted telisotuzumab vedotin in adult NSCLC patients with tumors with EGFR non squamous histology
Tanja Obradovic shared a post on LinkedIn: "Completely new treatment option by novel antibody-drug conjugate (ADC)…
Oct 2, 2024, 15:39 |
Blog
Tanja Obradovic: FDA ODAC's decision on PD-1 Inhibitors in HER2- Negative Gastric Cancer
Tanja Obradovic shared a post on LinkedIn: "In highly anticipated discussion on September 26th FDA Oncologic Drugs…
Oct 2, 2024, 08:24 |
Blog
Tanja Obradovic: FDA just approved Osimertinib for adult patients with locally advanced, unresectable non-small cell lung cancer
Tanja Obradovic shared a post on LinkedIn: ''FDA just approved Osimertinib (Tagrisso), a third-generation EGFR-directed…
Sep 30, 2024, 08:39 |
Opinion
Tanja Obradovic: Strategy of clinical development in oncology requires global considerations
Tanja Obradovic shared the following on LinkedIn: “Strategy of clinical development in oncology always encompasses…
Sep 28, 2024, 16:12 |
Blog
Tanja Obradovic: AACR issues Cancer Progress Report 2024 with a focus on young adults and children
Tanja Obradovic shared the following on LinkedIn: “AACR just issued Cancer Progress Report 2024, which…
Sep 28, 2024, 08:32 |
Blog
Tanja Obradovic: In order to achieve true breakthroughs in cancer therapy strong science needs to be accompanied with "thinking outside of the box"
Tanja Obradovic shared a post on LinkedIn: "As with everything road to successful drug development in…
Sep 25, 2024, 18:29 |
Insight
Tanja Obradovic: Ligufalimab plus ivonescimab combined with chemo in the first-line CRC patients
Tanja Obradovic shared a post on LinkedIn: "Tackling large medical need in microsatellite stable (MSS)…
Sep 14, 2024, 10:51 |
Blog
Tanja Obradovic: PIONeeR Project results will be presented at ESMO 2024 Presidential Symposium
Tanja Obradovic shared on LinkedIn: "Just announced that exciting results will be presented at ESMO…
Sep 10, 2024, 05:08 |
Blog
Tanja Obradovic: Two practice-changing trials of Keytruda within Presidential Symposium of ESMO24
Tanja Obradovic shared on LinkedIn: "ESMO 2024 will have two practice-changing trials of Keytruda (Pembrolizumab)…
1
2
3
4
5
All:
74
Posts:
1 - 10
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube